Loading
Latest filing published 22 Aug 2023 for Timber Pharmaceuticals, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Alan Mendelsohn on record concern Timber Pharmaceuticals, Inc., in the capacity of senior executive. The record holds 3 filings, for trades running from 3 March 2021 to 20 August 2023.
On the market, this insider has only ever bought: 2 purchases, €7,750 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant.
On 22 August 2023 came the latest disclosure, a share grant in Timber Pharmaceuticals, Inc. The clock since the last published purchase (24 November 2021) now reads 1,795 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations